Page last updated: 2024-09-04

carbapenems and mk-7655

carbapenems has been researched along with mk-7655 in 22 studies

Compound Research Comparison

Studies (carbapenems)	Trials (carbapenems)	Recent Studies (post-2010) (carbapenems)	Studies (mk-7655)	Trials (mk-7655)	Recent Studies (post-2010) (mk-7655)
7,355	147	5,277	140	9	136

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (13.64)	24.3611
2020's	19 (86.36)	2.80

Authors

Authors	Studies
Chang, KT; Hirsch, EB; Ledesma, KR; Motyl, MR; Schwartz, MS; Tam, VH	1
Ammerman, NC; Kaushik, A; Kreiswirth, BN; Lamichhane, G; Lee, J; Martins, O; Nuermberger, EL; Parrish, NM	1
Hsu, AJ; Tamma, PD	1
Sfeir, MM	1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A	1
Chahine, EB; Karaoui, LR; Mansour, H; Ouweini, AEL	1
Hsieh, YJ; Kao, LT; Lian, SH; Lin, IL; Liu, GH; Lu, PL; Tseng, SP; Wang, HY; Wang, LC; Yang, TY	1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E	1
Horwich-Scholefield, S; Huang, S; Lloyd, T; Pandori, M; Varghese, V; Yette, E	1
Arend, LNVS; Bail, L; Ito, CAS; Nogueira, KDS; Tuon, FF	1
Chen, L; Chen, T; Fang, R; Liao, W; Xu, C; Zhang, S; Zhou, C; Zhou, T	1
Lodise, TP; O'Donnell, JN	1
Birgy, A; Bonacorsi, S; Courroux, C; Danjean, M; Gits-Muselli, M; Hobson, CA; Monjault, A	1
Findlay, J; Nordmann, P; Poirel, L; Rens, C	1
Haines, RR; Hammer, KA; Putsathit, P; Tai, AS	1
König, E; Zollner-Schwetz, I	1
Carvalhaes, CG; Castanheira, M; Duncan, L; Kimbrough, JH; Mendes, RE; Sader, HS	1
Gu, Y; Hu, D; Hu, M; Liang, R; Wang, D; Wang, M; Zhu, M	1
DeRyke, CA; Hackel, M; Hilbert, DW; Motyl, M; Young, K	1
Lukovic, B; Petrovic, I; Zornic, S	1
Ahmed, A; Chryssanthou, E; Davies Forsman, L; Fröberg, G	1
Gill, CM; Lee, SY; Nicolau, DP	1

Reviews

5 review(s) available for carbapenems and mk-7655

Article	Year
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms. Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam	2019
The role of new antimicrobials for Gram-negative infections in daily clinical practice. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines	2020
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International journal of antimicrobial agents, 2021, Volume: 57, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin	2021
New Perspectives on Antimicrobial Agents: Imipenem-Relebactam. Antimicrobial agents and chemotherapy, 2022, 07-19, Volume: 66, Issue:7 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa	2022
Treatment options for multidrug-resistant Gram-negatives in urinary tract infections. Current opinion in urology, 2023, 05-01, Volume: 33, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Gram-Negative Bacterial Infections; Humans; Imipenem; Urinary Tract Infections	2023

Other Studies

17 other study(ies) available for carbapenems and mk-7655

Article	Year
In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Gram-Negative Bacteria; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Theoretical	2012
Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Boronic Acids; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous	2019
Imipenem-relebactam for Treatment of Carbapenem-resistant Gram-negative Bacteria: Where Do We Stand on In Vitro Susceptibility Testing? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 04-26, Volume: 72, Issue:8 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Carbapenems; Colistin; Double-Blind Method; Gram-Negative Bacteria; Humans; Imipenem	2021
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2021, 03-31, Volume: 78, Issue:8 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Humans; Imipenem; Microbial Sensitivity Tests	2021
Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2022, Volume: 55, Issue:1 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Caenorhabditis elegans; Carbapenems; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Microbial Sensitivity Tests; Taiwan	2022
Imipenem-Relebactam Susceptibility and Genotypic Characteristics of Carbapenem-Resistant Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gammaproteobacteria; Imipenem; Microbial Sensitivity Tests	2021
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales. Diagnostic microbiology and infectious disease, 2022, Volume: 102, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tazobactam	2022
In vitro activity of imipenem-relebactam alone and in combination with fosfomycin against carbapenem-resistant gram-negative pathogens. Diagnostic microbiology and infectious disease, 2022, Volume: 103, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Escherichia coli; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests	2022
Evaluation of the inoculum effect of new antibiotics against carbapenem-resistant enterobacterales. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefiderocol; Humans; Imipenem; Meropenem; Tazobactam	2022
Antimicrobial agents and chemotherapy, 2022, 10-18, Volume: 66, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests	2022
Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa. Scientific reports, 2022, 10-07, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Monobactams; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022). Diagnostic microbiology and infectious disease, 2023, Volume: 106, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; United States	2023
In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam alone or in combination with polymyxin B against carbapenem resistant Acinetobacter baumannii. The Journal of antibiotics, 2023, Volume: 76, Issue:9 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Drug Combinations; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymyxin B	2023
Relebactam restores susceptibility of resistant Pseudomonas aeruginosa and Enterobacterales and enhances imipenem activity against chromosomal AmpC-producing species: analysis of global SMART 2018-2020. BMC microbiology, 2023, 06-13, Volume: 23, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Gammaproteobacteria; Humans; Imipenem; Pseudomonas aeruginosa	2023
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia. Acta microbiologica et immunologica Hungarica, 2023, Sep-21, Volume: 70, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serbia	2023
The Antimicrobial agents and chemotherapy, 2023, 10-18, Volume: 67, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Combinations; Imipenem; Microbial Sensitivity Tests; Mycobacterium abscessus	2023
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2023, Dec-01, Volume: 78, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2023